Skip to main content


Meningococcal B Immunisation Programme

Media Releases

Phase Three Trials Were Not in the Best Interests of Children and Young People.

Since 1991 5600 cases of meningococcal disease have occurred in New Zealand.  The majority of these people have been cared for by members of our Society who sadly know too well what a terrifying brain and body destroying condition it can be.

With expert care and high levels of community awareness less than 5% of patients die but about 12% are left with permanent disability such as loss of limbs, brain damage or hearing loss.  Although the epidemic may have reached its peak we know without a vaccination programme it still has 6-10 years to run with about 3500 more cases, 600 suffering disability and 190 dying.

Such high levels of disease mean it was irresponsible to delay vaccination once an effective safe vaccine was available.

To do phase three trials tens of thousands of children would have to have been left unvaccinated while another group was vaccinated.  Over the following months the level of disease in the two groups would have been followed in detail.  In the UK and USA, as in New Zealand, good information on antibody production meant it was not considered necessary to do phase 3 trials.  To have done these trials in New Zealand would have substantially delayed protecting most of our children and young people with many tragic outcomes.  The Society feels that the Ministry of Health has responded to the epidemic with wise steps to protect our children and tackle a killer.  Each step of the development of this programme has been prudent and timely following the best advice available locally and overseas.  Our members look forward to fewer children and young people suffering and less need to break tragic news to families.

If parents and caregivers have concerns about vaccination for their child they should consult a health professional they trust.

Dr Nick Baker BSc.MBChB, DCH, FRACP


Paediatric Society of New Zealand Incorporated

21 Sep 2021
Media release 21 September 2021 New programme aims to improve respiratory outcomes for tamariki A new programme called ‘Koira 4 Rukahukahu’ or ‘Lungs 4 Life’ has recently been launched by the Northern Regional Alliance encompassing the three Auckland Metro DHBs…
07 Sep 2021
Kia ora koutou katoa Please find attached our current media release titled ‘Doctors Stand Up for Vaccination’. We welcome enquiries from all media outlets for our Aotearoa NZ President Dr George Laking. Ngā mihi nui Paula Birnie Senior Executive Officer | Member…
23 Aug 2021
Tēnā koe, Please find attached a RACP Media Release. Reset for equity: First dose of COVID-19 vaccines for Māori and Pasifika The Royal Australasian College of Physicians (RACP) tautoko the call of Te Rōpū Whakakaupapa Urutā for Māori and Pasifika to be…